BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wong RJ, Ahmed A. Obesity and non-alcoholic fatty liver disease: Disparate associations among Asian populations. World J Hepatol 2014; 6(5): 263-273 [PMID: 24868320 DOI: 10.4254/wjh.v6.i5.263]
URL: https://www.wjgnet.com/1948-5182/full/v6/i5/263.htm
Number Citing Articles
1
Mariana V. Machado, Sara Policarpo, J Coutinho, Sofia Carvalhana, Jorge Leitão, Armando Carvalho, Ana P. Silva, Francisco Velasco, Isabel Medeiros, Ana Catarina Alves, Mafalda Bourbon, Helena Cortez-Pinto. What Is the Role of the New Index Relative Fat Mass (RFM) in the Assessment of Nonalcoholic Fatty Liver Disease (NAFLD)?Obesity Surgery 2020; 30(2): 560 doi: 10.1007/s11695-019-04213-8
2
Pamela Valva, Daniela Rios, Paola Casciato, Adrián Gadano, Omar Galdame, Eduardo Mullen, Gustavo Bertot, Elena de Matteo, María V. Preciado. Nonalcoholic fatty liver diseaseEuropean Journal of Gastroenterology & Hepatology 2018; 30(6): 637 doi: 10.1097/MEG.0000000000001079
3
Shimin Wu, Hongjie Gao, Yumei Ma, Lina Fu, Cai Zhang, Xiaoping Luo. Characterisation of betatrophin concentrations in childhood and adolescent obesity and insulin resistancePediatric Diabetes 2016; 17(1): 53 doi: 10.1111/pedi.12233
4
Abhijit Chowdhury, Zobair M. Younossi. Alcoholic and Non-Alcoholic Fatty Liver Disease2016; : 21 doi: 10.1007/978-3-319-20538-0_2
5
Chandrajeet Yadav, Sandeep Dhruw, Pulkit Shekhawatia, Aman Gupta. SONOGRAPHICALLY DIAGNOSED NON-ALCOHOLIC FATTY LIVER AS A PREDICTOR OF METABOLIC SYNDROMEJournal of Evolution of Medical and Dental Sciences 2016; 5(15) doi: 10.14260/jemds/2016/166
6
Lin Liu, Hongmei Yan, MingFeng Xia, Lin Zhao, Minzhi Lv, Naiqin Zhao, Shengxiang Rao, Xiuzhong Yao, Weiyun Wu, Baishen Pan, Hua Bian, Xin Gao. Efficacy of exenatide and insulin glargine on nonalcoholic fatty liver disease in patients with type 2 diabetesDiabetes/Metabolism Research and Reviews 2020; 36(5) doi: 10.1002/dmrr.3292
7
Daniel Ferraz de Campos Mazo, Rejane Mattar, José Tadeu Stefano, Joyce Matie Kinoshita da Silva-Etto, Márcio Augusto Diniz, Sebastião Mauro Bezerra Duarte, Fabíola Rabelo, Rodrigo Vieira Costa Lima, Priscila Brizolla de Campos, Flair José Carrilho, Claudia P Oliveira. Hypolactasia is associated with insulin resistance in nonalcoholic steatohepatitisWorld Journal of Hepatology 2016; 8(24): 1019-1027 doi: 10.4254/wjh.v8.i24.1019
8
Warinda Susutlertpanya, Hirokazu Wakuda, Naoyuki Otani, Takuya Kuramoto, Li Li, Masae Kuranari, Ai Sekiguchi, Hideo Kudo, Tomohisa Uchida, Hiromitsu Imai, Naoto Uemura. Histological evaluation of nintedanib in non-alcoholic steatohepatitis miceLife Sciences 2019; 228: 251 doi: 10.1016/j.lfs.2019.05.014
9
Dahn Jeong, Mohammad Ehsanul Karim, Stanley Wong, James Wilton, Zahid Ahmad Butt, Mawuena Binka, Prince Asumadu Adu, Sofia Bartlett, Margo Pearce, Emilia Clementi, Amanda Yu, Maria Alvarez, Hasina Samji, Héctor Alexander Velásquez García, Younathan Abdia, Mel Krajden, Naveed Zafar Janjua. Impact of HCV infection and ethnicity on incident type 2 diabetes: findings from a large population-based cohort in British ColumbiaBMJ Open Diabetes Research & Care 2021; 9(1): e002145 doi: 10.1136/bmjdrc-2021-002145
10
Nima Motamed, Mahmoodreza Khoonsari, Mahshid Panahi, Nader Rezaie, Mansooreh Maadi, Fahimeh Safarnezhad Tameshkel, Hossein Keyvani, Mohammad Hadi Karbalaie Niya, Hossein Ajdarkosh, Seyyed Mohammad Miri, Farhad Zamani. The Incidence and Risk Factors of Non-Alcoholic Fatty Liver Disease: A Cohort Study from IranHepatitis Monthly 2020; 20(2) doi: 10.5812/hepatmon.98531
11
Sanda Mustapic, Sead Ziga, Vladimir Matic, Tomislav Bokun, Bozo Radic, Marko Lucijanic, Srecko Marusic, Zarko Babic, Ivica Grgurevic. Ultrasound Grade of Liver Steatosis Is Independently Associated with the Risk of Metabolic SyndromeCanadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/8490242
12
P. Praveen Raj, Rachel M. Gomes, Saravana Kumar, Palanisamy Senthilnathan, Purushothaman Karthikeyan, Annapoorni Shankar, Chinnusamy Palanivelu. The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: “NASHOST” prospective observational trialSurgery for Obesity and Related Diseases 2015; 11(6): 1315 doi: 10.1016/j.soard.2015.02.006
13
Sara Ashtari, Mohamad Amin Pourhoseingholi, Mohamad Reza Zali. Non-alcohol fatty liver disease in Asia: Prevention and planningWorld Journal of Hepatology 2015; 7(13): 1788-1796 doi: 10.4254/wjh.v7.i13.1788
14
Adam Schmitz, Paul Haste, Matthew S. Johnson. Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation Prior to Abdominal Operation: a Retrospective AnalysisJournal of Gastrointestinal Surgery 2020; 24(10): 2228 doi: 10.1007/s11605-019-04384-w
15
Sital Singh, Gabriela N. Kuftinec, Souvik Sarkar. Non-alcoholic Fatty Liver Disease in South Asians: A Review of the LiteratureJournal of Clinical and Translational Hepatology 2017; (XX): 1 doi: 10.14218/JCTH.2016.00045
16
Doreen Liou, Kathleen D. Bauer, Emily Fowler. Dietary Acculturation of Obesity Risk Reduction Behaviors in Chinese AmericansFamily and Consumer Sciences Research Journal 2018; 47(2): 130 doi: 10.1111/fcsr.12289
17
Asim Kichloo, Shantanu Solanki, Khwaja F Haq, Dushyant Dahiya, Beth Bailey, Dhanshree Solanki, Jagmeet Singh, Michael Albosta, Farah Wani, Michael Aljadah, Harshil Shah, Hafiz Khan, Syed-Mohammed Jafri. Association of non-alcoholic fatty liver disease with gallstone disease in the United States hospitalized patient populationWorld Journal of Gastrointestinal Pathophysiology 2021; 12(2): 14-24 doi: 10.4291/wjgp.v12.i2.14
18
Juan C Lopez-Delgado, Francisco Esteve, Casimiro Javierre, Josep L Ventura, Rafael Mañez, Elisabet Farrero, Herminia Torrado, David Rodríguez-Castro, Maria L Carrio. Influence of cirrhosis in cardiac surgery outcomesWorld Journal of Hepatology 2015; 7(5): 753-760 doi: 10.4254/wjh.v7.i5.753
19
Yaxi Chen, Zac Varghese, Xiong Z. Ruan. The molecular pathogenic role of inflammatory stress in dysregulation of lipid homeostasis and hepatic steatosisGenes & Diseases 2014; 1(1): 106 doi: 10.1016/j.gendis.2014.07.007
20
Rokaya Abd El-Aziz, Mervat Naguib, Laila A. Rashed. Spleen size in patients with metabolic syndrome and its relation to metabolic and inflammatory parametersThe Egyptian Journal of Internal Medicine 2018; 30(2): 78 doi: 10.4103/ejim.ejim_86_17
21
Jee-Fu Huang, Pei-Chien Tsai, Ming-Lun Yeh, Chung-Feng Huang, Ching-I. Huang, Meng-Hsuan Hsieh, Chia-Yen Dai, Jeng-Fu Yang, Shinn-Chern Chen, Ming-Lung Yu, Wan-Long Chuang, Wen-Yu Chang. Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basisJournal of the Formosan Medical Association 2020; 119(1): 89 doi: 10.1016/j.jfma.2019.03.014
22
Mi-Ok Sim, Hae-In Lee, Ju Ri Ham, Kwon-Il Seo, Mi-Kyung Lee. Long-term supplementation of esculetin ameliorates hepatosteatosis and insulin resistance partly by activating AdipoR2–AMPK pathway in diet-induced obese miceJournal of Functional Foods 2015; 15: 160 doi: 10.1016/j.jff.2015.03.014
23
Seung Ku Lee, Dae Wui Yoon, Si Woo Lee, Jong Yeol Kim, Jin Kwan Kim, Chol Shin. Non-alcoholic fatty liver disease among sasang constitutional types: a population-based study in KoreaBMC Complementary and Alternative Medicine 2015; 15(1) doi: 10.1186/s12906-015-0925-8
24
Cosmas Rinaldi A. Lesmana, Maria S. Paramitha, Irsan Hasan. Reference Module in Food Science2021;  doi: 10.1016/B978-0-12-819265-8.00079-6
25
Jie Han, Yaping He, Hui Zhao, Xiaowei Xu. Hypoxia inducible factor‐1 promotes liver fibrosis in nonalcoholic fatty liver disease by activating PTEN/p65 signaling pathwayJournal of Cellular Biochemistry 2019; 120(9): 14735 doi: 10.1002/jcb.28734
26
Bi-Ling Yang, Wen-Chieh Wu, Kuan-Chieh Fang, Yuan-Chen Wang, Teh-Ia Huo, Yi-Hsiang Huang, Hwai-I Yang, Chien-Wei Su, Han-Chieh Lin, Fa-Yauh Lee, Jaw-Ching Wu, Shou-Dong Lee, Silvia C. Sookoian. External Validation of Fatty Liver Index for Identifying Ultrasonographic Fatty Liver in a Large-Scale Cross-Sectional Study in TaiwanPLOS ONE 2015; 10(3): e0120443 doi: 10.1371/journal.pone.0120443
27
Anton Gillessen, Hartmut H.-J. Schmidt. Silymarin as Supportive Treatment in Liver Diseases: A Narrative ReviewAdvances in Therapy 2020; 37(4): 1279 doi: 10.1007/s12325-020-01251-y
28
María del Carmen Baez, Mariana Tarán, Mónica Moya, María de la Paz Scribano Parada. Modulation of Oxidative Stress in Heart Disease2019; : 313 doi: 10.1007/978-981-13-8946-7_12
29
Mark Yu Zheng Wong, Jonathan Jiunn Liang Yap, Mark Chang Chuen Cheah, George Boon Bee Goh, Khung Keong Yeo. Non-alcoholic fatty liver disease is associated with subclinical coronary artery disease in otherwise healthy individualsAnnals of the Academy of Medicine, Singapore 2021; 50(6): 500 doi: 10.47102/annals-acadmedsg.2020639
30
Amedeo Lonardo, Stefano Bellentani, Curtis K. Argo, Stefano Ballestri, Christopher D. Byrne, Stephen H. Caldwell, Helena Cortez-Pinto, Antonio Grieco, Mariana V. Machado, Luca Miele, Giovanni Targher. Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groupsDigestive and Liver Disease 2015; 47(12): 997 doi: 10.1016/j.dld.2015.08.004
31
Elina Petäjä, Hannele Yki-Järvinen. Definitions of Normal Liver Fat and the Association of Insulin Sensitivity with Acquired and Genetic NAFLD—A Systematic ReviewInternational Journal of Molecular Sciences 2016; 17(5): 633 doi: 10.3390/ijms17050633
32
Song-Huy Nguyen-Dinh, Albert Do, Trang Ngoc Doan Pham, Doan Y Dao, Trinh Nhu Nguy, Moon S Chen Jr. High burden of hepatocellular carcinoma and viral hepatitis in Southern and Central Vietnam: Experience of a large tertiary referral center, 2010 to 2016World Journal of Hepatology 2018; 10(1): 116-123 doi: 10.4254/wjh.v10.i1.116
33
Wei-Dong Li, Kun-Fa Fu, Gui-Mei Li, Yan-Shu Lian, Ai-Min Ren, Yun-Jue Chen, Jin-Rong Xia. Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitusWorld Journal of Gastroenterology 2015; 21(32): 9607-9613 doi: 10.3748/wjg.v21.i32.9607
34
Hirayuki Enomoto, Nobuhiro Aizawa, Hiroki Nishikawa, Naoto Ikeda, Yoshiyuki Sakai, Ryo Takata, Kunihiro Hasegawa, Chikage Nakano, Takashi Nishimura, Kazunori Yoh, Akio Ishii, Tomoyuki Takashima, Yoshinori Iwata, Hiroko Iijima, Shuhei Nishiguchi. Relationship Between Hepatic Steatosis and the Elevation of Aminotransferases in HBV-Infected Patients With HBe-Antigen Negativity and a Low Viral LoadMedicine 2016; 95(17): e3565 doi: 10.1097/MD.0000000000003565
35
Pushpjeet Kanwar, Kris V. Kowdley. The Metabolic Syndrome and Its Influence on Nonalcoholic SteatohepatitisClinics in Liver Disease 2016; 20(2): 225 doi: 10.1016/j.cld.2015.10.002
36
Lijing Zhang, Bin Yang, Baoping Yu. Paeoniflorin Protects against Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet in MiceBiological & Pharmaceutical Bulletin 2015; 38(7): 1005 doi: 10.1248/bpb.b14-00892
37
Andrea Garatti, Andrea Daprati, Marzia Cottini, Claudio F. Russo, Margherita Dalla Tomba, Giovanni Troise, Antonio Salsano, Francesco Santini, Roberto Scrofani, Francesca Nicolò, Elisa Mikus, Alberto Albertini, Luca Di Marco, Davide Pacini, Marco Picichè, Loris Salvador, Guglielmo M. Actis Dato, Paolo Centofanti, Domenico Paparella, Giorgios Kounakis, Alessandro Parolari, Lorenzo Menicanti. Cardiac Surgery in Patients With Liver Cirrhosis (CASTER) Study: Early and Long-Term OutcomesThe Annals of Thoracic Surgery 2021; 111(4): 1242 doi: 10.1016/j.athoracsur.2020.06.110
38
Myoung-Sun Lee, Joo-Seok Kim, Sun-Mi Cho, Seon Ok Lee, Sung-Hoon Kim, Hyo-Jeong Lee. FermentedRhus vernicifluaStokes Extract Exerts an Antihepatic Lipogenic Effect in Oleic-Acid-Induced HepG2 Cells via Upregulation of AMP-Activated Protein KinaseJournal of Agricultural and Food Chemistry 2015; 63(32): 7270 doi: 10.1021/acs.jafc.5b01954
39
Aneesah McClinton, Joy Gullo, Paulo N. Martins, Oscar K. Serrano. Access to liver transplantation for minority populations in the United StatesCurrent Opinion in Organ Transplantation 2021; 26(5): 508 doi: 10.1097/MOT.0000000000000904
40
Ta-Ya Lin, Ming-Lun Yeh, Chung-Feng Huang, Ching-I Huang, Chia-Yen Dai, Meng-Hsuan Hsieh, Shinn-Chern Chen, Jee-Fu Huang, Ming-Lung Yu, Wan-Long Chuang. Disease progression of nonalcoholic steatohepatitis in Taiwanese patients: a longitudinal study of paired liver biopsiesEuropean Journal of Gastroenterology & Hepatology 2019; 31(2): 224 doi: 10.1097/MEG.0000000000001285
41
S. Lallukka, H. Yki-Järvinen. Non-alcoholic fatty liver disease and risk of type 2 diabetesBest Practice & Research Clinical Endocrinology & Metabolism 2016; 30(3): 385 doi: 10.1016/j.beem.2016.06.006
42
Anna Janina Engstler, Cathrin Sellmann, Cheng Jun Jin, Annette Brandt, Kathleen Herz, Josephine Priebs, Ina Bergheim. Treatment with alpha-galactosylceramide protects mice from early onset of nonalcoholic steatohepatitis: Role of intestinal barrier functionMolecular Nutrition & Food Research 2017; 61(5): 1600985 doi: 10.1002/mnfr.201600985
43
Christopher R. Shepard. TLR9 in MAFLD and NASH: At the Intersection of Inflammation and MetabolismFrontiers in Endocrinology 2021; 11 doi: 10.3389/fendo.2020.613639
44
Maximilian Wetterkamp, Cornelius J. van Beekum, Maria A. Willis, Tim R. Glowka, Steffen Manekeller, Rolf Fimmers, Michael Praktiknjo, Johannes Chang, Joerg C. Kalff, Tim O. Vilz. Risk Factors for Postoperative Morbidity and Mortality after Small Bowel Surgery in Patients with Cirrhotic Liver Disease—A Retrospective Analysis of 76 Cases in a Tertiary CenterBiology 2020; 9(11): 349 doi: 10.3390/biology9110349
45
Akshay Shetty, Jennifer W. Hsu, Paul P. Manka, Wing-Kin Syn. Role of the Circadian Clock in the Metabolic Syndrome and Nonalcoholic Fatty Liver DiseaseDigestive Diseases and Sciences 2018; 63(12): 3187 doi: 10.1007/s10620-018-5242-x
46
Binxia Chang, Baosen Li, Ang Huang, Ying Sun, Guangju Teng, Xiaoxia Wang, Suthat Liangpunsakul, Jin Li, Zhengsheng Zou. Changes of four common non-infectious liver diseases for the hospitalized patients in Beijing 302 hospital from 2002 to 2013Alcohol 2016; 54: 61 doi: 10.1016/j.alcohol.2016.07.001
47
George B.B. Goh, Clarence Kwan, Sze Ying Lim, Nanda KK Venkatanarasimha, Rafidah Abu-Bakar, Thinesh L Krishnamoorthy, Hang Hock Shim, Kiang Hiong Tay, Wan Cheng Chow. Perceptions of non-alcoholic fatty liver disease – an Asian community-based studyGastroenterology Report 2016; 4(2): 131 doi: 10.1093/gastro/gov047
48
Shoukat Ali Samejo, Zaigham Abbas, Muhammad Asim. Effects of anthropometric and metabolic parameters on transaminase levels and liver stiffness in patients with non-alcohol fatty liver diseaseTropical Doctor 2021; 51(2): 185 doi: 10.1177/0049475520962742
49
Juan C Lopez-Delgado, Josep Ballus, Francisco Esteve, Nelson L Betancur-Zambrano, Vicente Corral-Velez, Rafael Mañez, Antoni J Betbese, Joan A Roncal, Casimiro Javierre. Outcomes of abdominal surgery in patients with liver cirrhosisWorld Journal of Gastroenterology 2016; 22(9): 2657-2667 doi: 10.3748/wjg.v22.i9.2657
50
Chiao-Lin Hsu, Fu-Zong Wu, Kung-Hung Lin, Yu-Hsun Chen, Pin-Chieh Wu, Yan-Hua Chen, Chi-Shen Chen, Wen-Hwa Wang, Guang-Yuan Mar, Hsien-Chung Yu. Role of Fatty Liver Index and Metabolic Factors in the Prediction of Nonalcoholic Fatty Liver Disease in a Lean Population Receiving Health CheckupClinical and Translational Gastroenterology 2019; 10(5): e00042 doi: 10.14309/ctg.0000000000000042
51
Letiția Adela Maria Streba, Cristin Constantin Vere, Ion Rogoveanu, Costin Teodor Streba. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: An open questionWorld Journal of Gastroenterology 2015; 21(14): 4103-4110 doi: 10.3748/wjg.v21.i14.4103
52
Zahra Dehnavi, Farkhonde Razmpour, Mahmoud Belghaisi Naseri, Mohsen Nematy, Seyed Ali Alamdaran, Hassan Ali Vatanparast, Mohsen Azimi Nezhad, Bita Abbasi, Azita Ganji. Fatty Liver Index (FLI) in Predicting Non-alcoholic Fatty Liver Disease (NAFLD)Hepatitis Monthly 2018; 18(2) doi: 10.5812/hepatmon.63227
53
Peter R. Galle, Masatoshi Kudo, Josep M. Llovet, Richard S. Finn, Mark Karwal, Denis Pezet, Tae‐You Kim, Tsai‐Sheng Yang, Sara Lonardi, Jiri Tomasek, Jean‐Marc Phelip, Yann Touchefeu, Su‐Jin Koh, Guido Stirnimann, Kun Liang, Kenyon D. Ogburn, Chunxiao Wang, Paolo Abada, Ryan C. Widau, Andrew X. Zhu, Pierre Nahon. Ramucirumab in patients with previously treated advanced hepatocellular carcinoma: Impact of liver disease aetiologyLiver International 2021;  doi: 10.1111/liv.14994
54
Hale Tuhan, Ayhan Abacı, Ahmet Anık, Gönül Çatlı, Tuncay Küme, Özlem Gürsoy Çalan, Sezer Acar, Ece Böber. Circulating betatrophin concentration is negatively correlated with insulin resistance in obese children and adolescentsDiabetes Research and Clinical Practice 2016; 114: 37 doi: 10.1016/j.diabres.2016.02.008
55
Doreen Liou, Jessica A. Karasik. Living Environment Considerations on Obesity Prevention Behaviors and Self-Efficacy among Chinese AmericansInternational Journal of Environmental Research and Public Health 2021; 18(17): 9322 doi: 10.3390/ijerph18179322
56
Vyacheslav Buko, Ilya Zavodnik, Bartlomiej Palecz, Artur Stepniak, Siarhei Kirko, Alexej Shlyahtun, Wiesława Misiuk, Elena Belonovskaya, Oxana Lukivskaya, Elena Naruta, Irina Kuzmitskaya, Tatsiana Ilyich, Bayarmaa Erdenebayar, Sluken Rakhmadieva. Betulin/2-hydroxypropyl-β-cyclodextrin inclusion complex: Physicochemical characterization and hepatoprotective activityJournal of Molecular Liquids 2020; 309: 113118 doi: 10.1016/j.molliq.2020.113118
57
Anita Krishnarao, Carmi S. Punzalan. National and Global Ethnicity Differences in Non-alcoholic Fatty Liver DiseaseCurrent Hepatology Reports 2020; 19(4): 429 doi: 10.1007/s11901-020-00552-8
58
Kurt Grüngreiff. Liver Research and Clinical Management2018;  doi: 10.5772/intechopen.73735
59
Deborah Edelman, Harmit Kalia, Maria Delio, Mustafa Alani, Karthik Krishnamurthy, Mortadha Abd, Adam Auton, Tao Wang, Allan W. Wolkoff, Bernice E. Morrow. Genetic analysis of nonalcoholic fatty liver disease within a Caribbean–Hispanic populationMolecular Genetics & Genomic Medicine 2015; 3(6): 558 doi: 10.1002/mgg3.168
60
Channa R. Jayasekera, Mindie H. Nguyen. Cancer Epidemiology Among Asian Americans2016; : 233 doi: 10.1007/978-3-319-41118-7_10
61
Aastha Jindal, Anusha Thadi, Kunwar Shailubhai. Hepatocellular Carcinoma: Etiology and Current and Future DrugsJournal of Clinical and Experimental Hepatology 2019; 9(2): 221 doi: 10.1016/j.jceh.2019.01.004
62
Jie You, Sha Huang, Gui-Qian Huang, Gui-Qi Zhu, Rui-Min Ma, Wen-Yue Liu, Ke-Qing Shi, Gui-Long Guo, Yong-Ping Chen, Martin Braddock, Ming-Hua Zheng. Nonalcoholic Fatty Liver DiseaseMedicine 2015; 94(5): e479 doi: 10.1097/MD.0000000000000479
63
Ian James Martins. Non-Alcoholic Fatty Liver Disease - Molecular Bases, Prevention and Treatment2018;  doi: 10.5772/intechopen.70581
64
Darnna E. Banks, Yael Bogler, Taft Bhuket, Benny Liu, Robert J. Wong. Significant disparities in risks of diabetes mellitus and metabolic syndrome among chronic hepatitis C virus patients in the U.S.Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2017; 11: S153 doi: 10.1016/j.dsx.2016.12.025
65
Anne-Catherine Schwarz, Adrian T. Billeter, Katharina M. Scheurlen, Matthias Blüher, Beat P. Müller-Stich. Comorbidities as an Indication for Metabolic SurgeryVisceral Medicine 2018; 34(5): 381 doi: 10.1159/000493291
66
Haw-Wen Chen, Chih-Ching Yen, Li-Li Kuo, Chia-Wen Lo, Chin-Shiu Huang, Chih-Chieh Chen, Chong-Kuei Lii. Benzyl isothiocyanate ameliorates high-fat/cholesterol/cholic acid diet-induced nonalcoholic steatohepatitis through inhibiting cholesterol crystal-activated NLRP3 inflammasome in Kupffer cellsToxicology and Applied Pharmacology 2020; 393: 114941 doi: 10.1016/j.taap.2020.114941
67
Safoora Nabavi, Maryam Rafraf, Mohammad-hossein Somi, Aziz Homayouni-Rad, Mohammad Asghari-Jafarabadi. Probiotic yogurt improves body mass index and fasting insulin levels without affecting serum leptin and adiponectin levels in non-alcoholic fatty liver disease (NAFLD)Journal of Functional Foods 2015; 18: 684 doi: 10.1016/j.jff.2015.08.031
68
Thomas Jensen, Amanda Wieland, Melanie Cree-Green, Kristen Nadeau, Shelby Sullivan. Clinical workup of fatty liver for the primary care providerPostgraduate Medicine 2019; 131(1): 19 doi: 10.1080/00325481.2019.1546532
69
Fatih Battal, Hakan Türkön, Nilüfer Aylanç, Hakan Aylanç, Şule Yıldırım, Nazan Kaymaz, Sema Uysal. Investigation of Blood Betatrophin Levels in Obese Children with Non-Alcoholic Fatty Liver DiseasePediatric Gastroenterology, Hepatology & Nutrition 2018; 21(2): 111 doi: 10.5223/pghn.2018.21.2.111
70
Luis Aldámiz-Echevarría, Javier de las Heras, María Luz Couce, Carlos Alcalde, Isidro Vitoria, María Bueno, Javier Blasco-Alonso, María Concepción García, Mónica Ruiz, Rafael Suárez, Fernando Andrade, Olatz Villate. Non-alcoholic fatty liver in hereditary fructose intoleranceClinical Nutrition 2020; 39(2): 455 doi: 10.1016/j.clnu.2019.02.019
71
Umair Iqbal, Brandon Perumpail, Daud Akhtar, Donghee Kim, Aijaz Ahmed. The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver DiseaseMedicines 2019; 6(1): 41 doi: 10.3390/medicines6010041
72
Bo Kyung Koo, Won Kim. ReplyClinical Gastroenterology and Hepatology 2021; 19(2): 413 doi: 10.1016/j.cgh.2020.04.044
73
Aynur Unalp-Arida, Constance E. Ruhl. Transient Elastography–Assessed Hepatic Steatosis and Fibrosis Are Associated With Body Composition in the United StatesClinical Gastroenterology and Hepatology 2021;  doi: 10.1016/j.cgh.2021.02.009
74
Kuen Cheh Yang, Hui-Fang Hung, Chia-Wen Lu, Hao-Hsiang Chang, Long-Teng Lee, Kuo-Chin Huang. Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin ResistanceScientific Reports 2016; 6(1) doi: 10.1038/srep27034
75
Rui-Bing Feng, Chun-Lin Fan, Qing Liu, Zhong Liu, Wei Zhang, Yao-Lan Li, Wei Tang, Ying Wang, Man-Mei Li, Wen-Cai Ye. Crude triterpenoid saponins from Ilex latifolia (Da Ye Dong Qing) ameliorate lipid accumulation by inhibiting SREBP expression via activation of AMPK in a non-alcoholic fatty liver disease modelChinese Medicine 2015; 10(1) doi: 10.1186/s13020-015-0054-9